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Background and Aims: ROR-alpha is a member of ligand-activated nu-
clear receptor superfamily of transcription factors. Melatonin and choles-
terol are two known ligands of ROR-alpha, both of which were shown to be
important for atherosclerosis. The aim of this study was to determine
differentially expressed miRNAs in coronary artery disease (CAD) patients,
and to test the dependence of their expression on ROR-alpha activity in
THP-1 macrophage cells.
Methods: The Agilent’s microarray analyses were performed to compare
plasma miRNA profiles of selected individuals with CAD (n¼4) and non-
CAD (n¼3). Promo transcription factor binding site prediction tool was
used to identify ROR-alpha response elements (ROREs) in promoter of
selected miRNAs genes. Furthermore, THP-1 macrophage cells were
treated with simvastatin and ROR-alpha specific ligands (CPG52608 and
SR1001) and the expressions of differentially expressed miRNAs were
analyzed.
Results: Microarray results indicate that miR-19a and miR-26a were
significantly up-regulated in CAD patients compared to non-CAD group
(fold change>1.5, p<0.05). We identified ROREs within the promoter re-
gions of miR-19a host gene MIR17HG and miR-26a host gene CTDSP2/
CTDSPL. In addition, we observed that simvastatin repressed the expres-
sion of miR-19a and miR-26a, and this repression was partially increased
by SR1001 for miR-26a in macrophage cells. While repressor effect of
simvastatin was more clear in miR-26a, its prevention by CPG52608 was
observed to be more effective in miR-19a and miR-26a.
Conclusions: Our results suggest that miR-19a host gene MIR17HG and
miR-26a host gene CTDSP2/CTDSPL are potential target genes of ROR-alpha.
It seems also that ROR-alpha may control various genes indirectly through
miRNA clusters.
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EZETIMIBE PROTECTS THP-1 CELLS FROM ISCHEMIA-REPERFUSION
INJURY REDUCING OXIDATIVE STRESS AND UP-REGULATING NRF2/
ARE GENE EXPRESSION
D. Peserico, C. Stranieri, U. Garbin, A.M. Fratta Pasini. University of Verona,
Department of Medicine- Section of Internal Medicine and Atherothrombotic
and Degenerative Diseases, Verona, Italy
Background and Aims: We demonstrated that physical training, charac-
terized by repeated ischemia-reperfusion (I-R) episodes (ischemic condi-
tioning, IC), protects circulating cells from peripheral artery disease (PAD)
patients against ischemic harms by reducing oxidative stress (OS) and by
up-regulating nuclear factor erythroid 2-related factor 2 (Nrf2)/antioxi-
dant response element (ARE) pathway expression. Ezetimibe (Eze) has
been shown to alleviate OS enhancing Nrf2 nuclear translocation in an
AMPK/p62-dependent manner. In a cellular I-R and IC model, we aimed to
investigate: 1) the effect of Eze on OS and Nrf2/ARE gene expression 2)
whether Eze could have a synergistic effect on IC.
Methods: THP-1 cells were treated with or without Eze (50mM) overnight,
then subjected to 1 or 6 repetitive I-R cycles using EVOS FL Auto Imaging
System. Reactive oxygen species (ROS) formation was evaluated with DCF
in cytofluorimetry. Nrf2/ARE and p62 gene expression were evaluated by
RT-PCR and western blotting.
Results: When THP-1 cells were exposed to 1 I-R cycle, the preincubation
with Eze significantly reduced ROS formation (p<0.01) and up-regulated
Nrf2/ARE pathway expression and p62 phosphorylation (p<0.001). Mul-
tiple I-R cycles, acting as IC, significantly reduced ROS formation and up-
regulated Nrf2/ARE gene expression (p<0.001); in these conditions, Eze
preincubation was able not only to almost abolish ROS formation (p<0.01)
but also further up-regulate Nrf2/ARE expression.
Conclusions: In our I-R model, Eze not only restores I-R-induced oxidative
damages through Nrf2/ARE signaling up-regulation but also has a syner-
gistic effect on IC. This new “pleiotropic” effect, if confirmed in vivo, may
strengthen the use of Eze in PAD patients.Posters 26 - 29 May, 2019
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DEVELOPMENT OF TRANSGENIC MOUSE MODEL SUPERPRODUCER
SEALIDASE WITH SECRETION INTO THE BLOOD
V. Kalmykov, K. Vinogradov, M. Zamkova. Institute of Biology Gene Russian
Academy of Sciences, Centre of collective usage, Moscow, Russia
Background and Aims: Create a mouse model with inducible over-
expression of neuraminidase (sialidase) in the blood. Neuraminidase
(sialidase) is an enzyme that performs the desialylation of low density li-
poproteins. Increased sialidase activity is observed in the blood of patients
with atherosclerosis.
Methods: To obtain the superproducer of neuraminidase, we plan to use
the Mus musculus Neu3 gene cDNA with a secretion signal from the cell,
which will be inserted into the vector with a stop tape surrounded by loxP
sites under the b-actin promoter. Genetic construction involves the
random insertion of the transgene. The export sequence of the albumin
export site, 1 to 18 amino acids of the N domain of albumin, will be used as
a secretion signal to the blood. Tissue-specific lysozyme M promoter will
provide Neu3 expression in macrophages / neutrophils after crossing
recombinase-producing Cre mice with Neu3 mice with a stop tape sur-
rounded by loxP sites. Primary transgenes will be obtained by microin-
jection of the genetic construct into the pronucleus of the ovum.
Results: After crossing the obtained line of transgenic animals with a
transgenic line of mice expressing the Cre recombinase under the lysozyme
M promoter, we obtain the line mouse superproducers of neuraminidase
expressed in the blood.
Conclusions: Our approach will allow investigating the role of free siali-
dase in the blood for the development of atherogenesis, including against
the background of the Apoemutation - -. This workwas sapportid by grand
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A NOVEL HYPOTHESIS: ERYTHROCYTE SENESCENCE PLAYS A KEY ROLE
IN THE ATHEROSCLEROSIS DEVELOPMENT
A. Deykin 1, Y. Silaeva 1, E. Leonova 2. 1 Institute of Gene Biology Russian
Academy of Sciences, Сentre of collective usage, Moscow, Russia; 2 St.
Petersburg State University, Institute of Translational Biomedicine, St.
Petersburg, Russia
Background and Aims: Atherosclerosis is a chronic inflammatory disease
of the arterial wall characterized by chronic inflammation, high blood
pressure, oxidative stress, and progressive loss of cell and organ function
with aging. We propose a hypothesis that the development of athero-
sclerosis is based on oxidative stress of erythrocytes and their senescence.
Methods: Our hypothesis is based on several facts. At the first, it is known
that cholesterol content is increased in membrane of senescent erythro-
cytes. The second, senescent erythrocytes lose their plasticity and ability of
deformation, which affects the rheological blood properties, that can
injure the vessel wall. The third, macrophages are involved in all stages of
atherogenesis. They can undergo polarization by shifting between M1 and
M2 functional phenotypes.
Results: It is known that efferocytosis, or ingestion of apoptotic cells, is
stimulated by M2 macrophage polarization and macrophage polarization
toward the pro-inflammatory M1 macrophage is a major promoter to
atheroma formation. It is known that efferocytosis, or ingestion of apoptotic
cells, is stimulated byM2macrophage polarization. A failure of efferocytosis
leads to a prolongation of chronic pathology in tissue. In addition, fat-laden
macrophages contribute to plague progression by transforming into foam
cells in response to excess lipid deposition in arteries. We postulate that
